The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The prognostic value of semi-quantitative 123I mIBG scintigraphy at diagnosis in high-risk neuroblastoma: Validation of the SIOPEN score method.
V. Lewington
No relevant relationships to disclose
U. Poetschger
No relevant relationships to disclose
A. Boubaker
No relevant relationships to disclose
Z. Bar-Sever
No relevant relationships to disclose
B. Drake
No relevant relationships to disclose
A. Staudenherz
No relevant relationships to disclose
M. R. Castellani
No relevant relationships to disclose
B. Lambert
No relevant relationships to disclose
K. Grange
No relevant relationships to disclose
P. Brock
No relevant relationships to disclose
A. Garaventa
No relevant relationships to disclose
I. Yaniv
No relevant relationships to disclose
D. Valteau Couanet
No relevant relationships to disclose
V. Castel
No relevant relationships to disclose
A. Forjaz De Lacerda
No relevant relationships to disclose
J. Malis
No relevant relationships to disclose
H. Schroeder
No relevant relationships to disclose
R. Luksch
No relevant relationships to disclose
K. Beiske
No relevant relationships to disclose
R. L. Ladenstein
No relevant relationships to disclose